Cargando…

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

BACKGROUND: The prognostic relevance of circulating tumour cells (CTCs) in metastatic breast cancer (MBC) patients has been confirmed by several clinical trials. However, predictive blood-based biomarkers for stratification of patients for targeted therapy are still lacking. The DETECT studies explo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krawczyk, Natalia, Neubacher, Melissa, Meier-Stiegen, Franziska, Neubauer, Hans, Niederacher, Dieter, Ruckhäberle, Eugen, Mohrmann, Svjetlana, Hoffmann, Jürgen, Kaleta, Thomas, Banys-Paluchowski, Malgorzata, Reinecke, Petra, Esposito, Irene, Janni, Wolfgang, Fehm, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852746/ https://www.ncbi.nlm.nih.gov/pubmed/31718606 http://dx.doi.org/10.1186/s12885-019-6323-8

Ejemplares similares

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Circulating and Disseminated Tumour Cells in Breast Carcinoma: Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Invasive Breast Carcinoma with Neuroendocrine Differentiation: A Single-Center Analysis of Clinical Features and Prognosis
por: Krawczyk, Natalia, et al.
Publicado: (2021)

Evaluation of Intraoperative Frozen Section Analysis with Final Histopathology Results for Sentinel Lymph Node Biopsy: Z0011 Criteria Eligible Versus Ineligible Breast Cancer Patients
por: Reinhardt, Florian, et al.
Publicado: (2022)

Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2016)

Magnetic resonance imaging findings of high-grade ductal carcinoma in situ of the male breast: A case report
por: Reinhardt, Florian, et al.
Publicado: (2018)

Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
por: Reinhardt, Florian, et al.
Publicado: (2019)

Liquid Biopsy in Breast Cancer
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2020)

Circulating and Disseminated Tumor Cells in Breast Carcinoma: Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
por: Jaeger, Bernadette Anna Sophia, et al.
Publicado: (2023)

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies
por: Krawczyk, Natalia, et al.
Publicado: (2022)

The Role and Clinical Relevance of Disseminated Tumor Cells in Breast Cancer
por: Banys, Malgorzata, et al.
Publicado: (2014)

Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation
por: Jazmati, Danny, et al.
Publicado: (2022)

Post-Neoadjuvant Treatment Strategies in Breast Cancer
por: Matuschek, Christiane, et al.
Publicado: (2022)

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast Cancer
por: Krawczyk, Natalia, et al.
Publicado: (2022)

Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: A case report and review of the literature
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2016)

Twinkle artifact in sonographic breast clip visualization
por: Maggie, Banys-Paluchowski, et al.
Publicado: (2022)

Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
por: Müller, V., et al.
Publicado: (2021)

Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
por: Franken, André, et al.
Publicado: (2023)

PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
por: Bai, Yingxue, et al.
Publicado: (2021)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2017)

Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2020)

The effects of a music intervention during port catheter placement on anxiety and stress
por: Schaal, Nora K., et al.
Publicado: (2021)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM(high) and EpCAM(low/negative) CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer
por: Lampignano, Rita, et al.
Publicado: (2017)

Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2021)

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
por: Banys, Malgorzata, et al.
Publicado: (2013)

DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
por: Reinhardt, Florian, et al.
Publicado: (2023)

Recent advances in radiotherapy of breast cancer
por: Haussmann, Jan, et al.
Publicado: (2020)

EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2015)

Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2016)

Predictors of Impaired Postpartum Renal Function in Women after Preeclampsia: Results of a Prospective Single Center Study
por: Kaleta, T., et al.
Publicado: (2016)

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017)

Conventional Imaging, MRI and (18)F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
por: Morawitz, Janna, et al.
Publicado: (2023)

Axillary surgery in the case of limited involved axillary lymph nodes
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o9mvhjvepod01q42b1989bldsv